Literature DB >> 4125162

Levodopa and L-tryptophan therapy in Parkinsonism.

A Coppen, M Metcalfe, J D Carroll, J G Morris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4125162     DOI： 10.1016/s0140-6736(72)90461-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  L-Tryptophan: Biochemical, nutritional and pharmacological aspects.

Authors:  E L Sainio; K Pulkki; S N Young
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

Review 2.  Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data.

Authors:  B Scholtissen; F R J Verhey; H W M Steinbusch; A F G Leentjens
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

3.  Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD.

Authors:  Clare Loane; Kit Wu; Peter Bain; David J Brooks; Paola Piccini; Marios Politis
Journal:  Neurology       Date:  2013-04-17       Impact factor: 9.910

4.  Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory.

Authors:  B E Levin; M M Llabre; W J Weiner
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-11       Impact factor: 10.154

Review 5.  Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease.

Authors:  P Jenner; M Sheehy; C D Marsden
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.